AI-Based Foundation Models for Medical Image Segmentation: A Scientific Review for Clinical Practice

Abstract

The integration of artificial intelligence (AI)-based foundation models into medical image segmentation is revolutionizing diagnostic imaging and clinical decision-making. This review synthesizes current evidence, mechanisms, and clinical relevance of AI foundation models in medical image segmentation, with a focus on their epidemiological impact, underlying technical pathophysiology, risk factors for implementation, as well as their clinical, diagnostic, and therapeutic implications. Recent advances and emerging therapies are highlighted, along with contemporary guideline recommendations. The article aims to provide healthcare professionals with a comprehensive, evidence-based overview to facilitate informed adoption and optimization of AI-driven segmentation in clinical workflows.

Introduction

Medical image segmentation is fundamental for accurate diagnosis, disease characterization, treatment planning, and outcome prediction. Traditional segmentation approaches, reliant on manual delineation or classical algorithms, are time-consuming and susceptible to inter-observer variability. The advent of AI-based foundation models large pre-trained neural networks adaptable to diverse tasks has catalyzed a paradigm shift in this domain. Foundation models, such as Vision Transformers (ViTs) and large convolutional neural networks (CNNs), pre-trained on vast datasets, exhibit unprecedented generalizability and robustness. This review critically examines the implications of these models in clinical radiology, pathology, and other imaging fields, synthesizing their scientific underpinnings, recent evidence, and practical integration into healthcare.

Epidemiology / Disease Burden

The global burden of non-communicable diseases, including cancer, cardiovascular, and neurodegenerative disorders, underscores the need for precise and scalable imaging tools. Imaging modalities like MRI, CT, PET, and ultrasound generate vast data volumes, with estimates indicating over 3.6 billion imaging procedures annually worldwide. Manual segmentation is a major bottleneck, contributing to diagnostic delays and variability. AI-based foundation models promise to alleviate this burden by enabling high-throughput, automated segmentation, particularly in resource-limited settings or high-volume centers. Their adoption is poised to address disparities in imaging access and quality, thus impacting global disease outcomes.

Pathophysiology

Foundation models for medical image segmentation operate via deep learning architectures capable of extracting hierarchical features from imaging data. Pre-training on large-scale datasets, often non-medical (e.g., ImageNet), imparts generalizable feature representations. Subsequent fine-tuning on medical images enables the model to adapt to specific tasks such as organ, lesion, or tissue segmentation. Mechanistically, these models leverage self-attention mechanisms (in transformers) or hierarchical convolutions (in CNNs) to capture both global context and local details. The ability to generalize across imaging modalities and body regions, while incorporating multi-modal data (e.g., radiology with clinical records), distinguishes foundation models from conventional task-specific networks.

Risk Factors

Despite their promise, foundation models introduce several risk factors. Data heterogeneity, including variations in imaging protocols, scanner types, and patient populations, can impact model performance. Potential biases embedded in training data may propagate disparities in segmentation accuracy, particularly for underrepresented groups. Adversarial vulnerabilities where small image perturbations cause significant mis-segmentation pose safety risks. Additionally, the "black box" nature of deep models challenges interpretability and clinician trust. Regulatory, ethical, and cybersecurity concerns, including data privacy and model misuse, must be proactively managed to ensure safe and equitable implementation.

Clinical Features

AI-based foundation models have demonstrated utility in the segmentation of a wide spectrum of clinical features: tumor boundaries in oncology, infarct zones in stroke, plaque burden in cardiology, and anatomical delineations in surgery. Their capacity for three-dimensional, volumetric analysis enables more accurate quantification of disease burden and progression. Notably, these models support multi-organ, multi-modal, and even multi-disease segmentation from a single input image, facilitating holistic patient assessment. Advanced models can integrate temporal information, enabling segmentation across serial imaging studies for robust disease monitoring.

Diagnosis

Accurate segmentation is integral to diagnostic precision, influencing downstream processes such as radiomic analysis, computer-aided diagnosis, and image-guided interventions. Foundation models have outperformed classical and even existing deep learning models in benchmark tasks, achieving Dice similarity coefficients above 0.9 in multiple organ-based challenges. Their ability to delineate subtle pathological changes supports early diagnosis and risk stratification, especially in complex cases where manual segmentation is unreliable. Automated segmentation also enhances reproducibility and standardization, critical for multi-center studies and clinical trials.

Treatment & Management

In clinical practice, segmentation outputs from foundation models facilitate personalized treatment planning such as radiation therapy dosing, surgical navigation, and minimally invasive procedures. By rapidly quantifying lesion volumes and spatial relationships, these models inform therapeutic decisions and prognostic assessments. Integration with electronic health records (EHRs) and decision support tools augments multidisciplinary care coordination. Furthermore, real-time segmentation during interventions, enabled by AI, can enhance procedural safety and outcomes.

Recent Advances / Emerging Therapies

Recent breakthroughs include the development of self-supervised and few-shot learning paradigms, enabling foundation models to learn from limited or unlabeled medical data. Multi-modal foundation models combining images, text, and genomic data are emerging, supporting more comprehensive decision-making. Federated learning approaches allow collaborative model training across institutions without centralized data sharing, enhancing generalizability while preserving privacy. Large-scale initiatives, such as the Medical Segmentation Decathlon and MONAI framework, are standardizing benchmarks and accelerating clinical translation. Emerging therapies leveraging AI-segmented images include precision oncology, radiogenomics, and automated surgical robotics.

Guideline Recommendations

Professional societies, including the Radiological Society of North America (RSNA) and the European Society of Radiology (ESR), endorse the responsible adoption of AI in imaging, emphasizing rigorous validation, transparency, and clinician involvement. Guidelines recommend prospective clinical trials, external validation cohorts, and continuous post-deployment monitoring for AI segmentation tools. Interoperability standards, such as DICOM-SEG, are advocated to ensure seamless integration into clinical workflows. Multidisciplinary oversight including clinicians, data scientists, and ethicists is essential for safe, equitable, and patient-centered implementation.

Conclusion

AI-based foundation models are reshaping medical image segmentation, offering transformative potential for diagnostic accuracy, workflow efficiency, and personalized care. Their successful integration hinges on robust validation, ethical stewardship, and clinician engagement. Ongoing research and evolving guidelines will drive the maturation of these technologies, ultimately improving patient outcomes across diverse healthcare settings.